neoSurgical® is a commercial-stage company focused on being a global leader in the development of innovative surgical products. The company’s initial product is neoClose®, approved for sale in the U.S. and Europe and designed to be the new standard for Lap surgery port site closure, a potential $300 million opportunity.
Looking for a particular neoSurgical employee's phone or email?
The neoSurgical annual revenue was $1 million in 2026.
Brad Burke is the Owner and Director of neoSurgical.
2 people are employed at neoSurgical.
neoSurgical is based in Newton, Massachusetts.
The NAICS codes for neoSurgical are [32541, 32, 3254, 325].
The SIC codes for neoSurgical are [384, 38].